Cargando…
A combination pharmacotherapy of tapentadol and pregabalin to tackle centrally driven osteoarthritis pain
BACKGROUND: Many Osteoarthritis (OA) patients report with clinical features to their pain that cannot be explained by purely peripheral mechanisms. Yet, the analgesic agents available that tackle centrally driven chronic pain often provide only partial pain relief, or have dose‐limiting side effects...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618140/ https://www.ncbi.nlm.nih.gov/pubmed/30821870 http://dx.doi.org/10.1002/ejp.1386 |